← FDA Drug Approvals (Drugs@FDA)

RISPERIDONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2024-06-26

Drug application

FDA Application #

ANDA205104

Application type

Abbreviated New Drug Application (Generic)

Brand name

RISPERIDONE

Generic name

Risperidone

Active ingredients

RISPERIDONE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

IPCA LABS LTD

First approval

2024-06-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown